CYTK FY 2018 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M+135.6% YoY

Gross Profit

-$58M-183.0% margin

Operating Income

-$89M-282.3% margin

Net Income

-$106M-337.4% margin

EPS (Diluted)

$-1.95

Cash Flow

Operating Cash Flow

-$101M

Free Cash Flow

-$102M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$211M

Total Liabilities

$185M

Stockholders' Equity

$26M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$13M	+135.6%
Gross Profit	-$58M	-$77M	+25.1%
Operating Income	-$89M	-$113M	+21.6%
Net Income	-$106M	-$128M	+16.8%